Literature DB >> 1446708

Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.

P Pierre1, O Denis, H Bazin, E Mbongolo Mbella, J P Vaerman.   

Abstract

Oral administration to mice of ovalbumin (OVA), if given together with cholera toxin (CT) or its B subunit (CTB) prevented the hyporesponsiveness to OVA subsequently injected parenterally. Oral immunization with CT plus OVA or OVA plus CTB in fact primed the immune system, inducing a stronger response to a subsequent parenteral injection of OVA with complete Freund's adjuvant than in mice prefed only with OVA or with saline. Oral CT plus OVA also induced good serum IgG1 and IgA anti-OVA responses, with slightly (not significant) decreased IgG2a and IgG2b responses. Our in vivo findings agree well with earlier in vitro data from others, including CT inhibition of the Th1 CD4+ T cell subset and with CT effect on B cells (induction of LPS-stimulated IgM+ B cells to undergo increased switch differentiation to IgG1- and IgA-secreting cells).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446708     DOI: 10.1002/eji.1830221223

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Bisphosphonates target B cells to enhance humoral immune responses.

Authors:  Elena Tonti; Nereida Jiménez de Oya; Gabriele Galliverti; E Ashley Moseman; Pietro Di Lucia; Angelo Amabile; Stefano Sammicheli; Marco De Giovanni; Laura Sironi; Nicolas Chevrier; Giovanni Sitia; Luigi Gennari; Luca G Guidotti; Ulrich H von Andrian; Matteo Iannacone
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

2.  Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity.

Authors:  S Garg; V Bal; S Rath; A George
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Specific T-cell tolerance may be preceded by a primary response.

Authors:  L Vidard; L J Colarusso; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 4.  Oral tolerance.

Authors:  H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.

Authors:  Franck Biet; Laurent Kremer; Isabelle Wolowczuk; Myriam Delacre; Camille Locht
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice.

Authors:  E F Verdù; P Bercik; B Cukrowska; M A Farre-Castany; H Bouzourene; E Saraga; A L Blum; I Corthésy-Theulaz; H Tlaskalova-Hogenova; P Michetti
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

7.  Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance.

Authors:  Alfred D Eaton; Damo Xu; Paul Garside
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

8.  KDP, a Lactobacilli Product from Kimchi, Enhances Mucosal Immunity by Increasing Secretory IgA in Mice and Exhibits Antimicrobial Activity.

Authors:  Mamdooh Ghoneum; Shaymaa Abdulmalek
Journal:  Nutrients       Date:  2021-11-04       Impact factor: 5.717

9.  Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.

Authors:  Fengmin Zhou; Amanda Goodsell; Yasushi Uematsu; Michael Vajdy
Journal:  Clin Vaccine Immunol       Date:  2009-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.